Enanta Pharmaceuticals, Inc. News Headlines

Get ENTA Alerts
*Delayed - data as of Dec. 26, 2014 12:17 ET  -  Find a broker to begin trading ENTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENTA Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
12/24/2014 9:03:02 AM - Motley Fool

AbbVie Inc. Throws First Punch in Hep C Price War With Gilead Sciences, Inc.
12/23/2014 9:19:03 AM - Motley Fool

Enanta Is The Big Winner In The Hepatitis C War Between AbbVie And Gilead
12/23/2014 8:47:00 AM - Seeking Alpha

JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News

FDA Okays AbbVie's Viekira Pak To Treat Hepatitis C
12/19/2014 6:49:00 PM - RTT News

Tiger Media Agrees To Acquire Interactive Data - Quick Facts
12/15/2014 8:19:00 AM - RTT News

1 Big FDA Decision I'm Watching This Month
12/4/2014 9:15:09 AM - Motley Fool

5 Stocks to Watch Closely for the Rest of 2014
12/1/2014 11:02:16 AM - InvestorPlace Media

2nd Half Of 2014 Biotechnology Catalysts: Part 5
12/1/2014 9:59:00 AM - Seeking Alpha

Very Exciting Days Are In Store For Enanta Stockholders
11/27/2014 10:00:00 AM - Seeking Alpha

Company News for November 25, 2014 - Corporate Summary
11/25/2014 10:10:00 AM - Zacks.com

Can Partnering To Fight Hepatitis C Pay At Enanta?
11/24/2014 4:44:00 PM - Investor's Business Daily

Enanta Pharma Loss Narrower Than Estimates, Revenue Misses
11/24/2014 11:20:00 AM - RTT News

Health Care Sector Update for 11/24/2014: TTPH, ENTA
11/24/2014 9:27:36 AM - MT Newswires

Enanta And AbbVie's ABT-450 Likely To Receive FDA Approval
11/18/2014 11:13:00 AM - Seeking Alpha

Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha

Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
11/7/2014 8:45:02 AM - Motley Fool

AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog
10/21/2014 3:32:00 PM - Zacks.com

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape
10/21/2014 7:44:00 AM - Zacks.com

Enanta Not To Exercise Co-development Option For ABT-493 - Update
10/21/2014 12:01:00 AM - RTT News

Enanta Not To Exercise Co-development Option For ABT-493
10/20/2014 6:24:00 PM - RTT News

End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies
10/20/2014 7:40:00 AM - Seeking Alpha

A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now
10/17/2014 1:54:00 PM - Seeking Alpha

ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape
10/17/2014 8:32:00 AM - Zacks.com